Holen Sie sich die Stockscreener-App
0.00
100.00%
-6.81
Schlusskurs vom Vortag:
$6.81
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$15.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-67.28M
KGV:
0.00
EPS:
-94.66
Netto-Cashflow:
$-9.80M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$15.82
Portage Biotech Inc Stock (PRTG) Company Profile
Firmenname
Portage Biotech Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PRTG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
0.00 | 15.86M | 0 | -67.28M | -9.80M | -94.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.80 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.61 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
861.40 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.27 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
199.31 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-03-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-21 | Eingeleitet | Oppenheimer | Outperform |
| 2021-09-02 | Eingeleitet | B. Riley Securities | Buy |
| 2021-08-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
Portage Biotech Inc Aktie (PRTG) Neueste Nachrichten
Mangalam Alloys Limited Tests 50 Day MA After Sharp DeclineAnalyst Upgrades & Free Phenomenal Trading Returns - Bollywood Helpline
Shervani Industrial Syndicate Limited Hits Oversold Level on RSI IndicatorStock Buyback Announcements & Technical + Fundamental = Smarter Investing - Bollywood Helpline
Is This the Dip to Buy in PB Fintech LimitedPrice Action Analysis & Investment Portfolio Recommendations - Bollywood Helpline
Price Floor Holding on Cranes Software International Limited — Rebound PossibleCandlestick Trading Patterns & Stay Ahead With Daily Market Discussions - Bollywood Helpline
AlphaTON Capital Corp Announces First Major Data Center Agreement with atNorth, Securing 2.2 MW of High-Performance Computing Capacity in Sweden - markets.businessinsider.com
AlphaTON Capital World Tour Lands at Abu Dhabi Finance Week - markets.businessinsider.com
AlphaTON Capital Deploys First H200 GPUs on Cocoon AI Network, Launches Revolutionary #OwnYourNode Program to Democratize AI Infrastructure Ownership - markets.businessinsider.com
AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event - marketscreener.com
AlphaTON Capital Exits SEC “Baby-Shelf Rules” and Files $420.69 Million Shelf Registration Statement - markets.businessinsider.com
Why Portage Biotech Inc. stock is a value investor pickTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - Newser
Will Portage Biotech Inc. stock beat EPS estimatesJuly 2025 Opening Moves & Low Risk Entry Point Guides - Newser
Can Portage Biotech Inc. stock beat market expectations this quarterPortfolio Performance Report & Intraday High Probability Alerts - BỘ NỘI VỤ
Is Portage Biotech Inc. stock overvalued by current metricsEarnings Miss & AI Enhanced Trading Alerts - BỘ NỘI VỤ
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025 - ADVFN
AlphaTON Capital Initiates $15.3M ATM Offering - TipRanks
Portage Biotech Stock Surges On New Preclinical Data In Mesothelioma Trial: Retail Gets More Bullish - MSN
ATON launches $15.3M at-the-market ordinary share program - Stock Titan
AlphaTON Capital Clarifies Equity Line and Expands Strategic Initiatives - The Globe and Mail
Portage Biotech’s After-Hours Surge On Preclinical Tumor Trial Data Sends Retail Optimism Sky-High - MSN
Why analysts upgrade Portage Biotech Inc. stockQuarterly Growth Report & Low Drawdown Trading Strategies - newser.com
AlphaTON Bolsters Tech Leadership with New CTO to Drive AI Growth - markets.businessinsider.com
Will Portage Biotech Inc. stock outperform growth indexesTrade Exit Summary & Safe Entry Zone Identification - newser.com
AlphaTON Capital (Nasdaq: ATON) Details TON Treasury, GAMEE Acquisition and 7% Debt - Stock Titan
How to integrate Portage Biotech Inc. into portfolio analysis tools2025 Market Outlook & Low Drawdown Momentum Trade Ideas - newser.com
Published on: 2025-11-19 21:57:05 - newser.com
Analyzing Portage Biotech Inc. with multi timeframe chartsEarnings Overview Summary & Weekly Top Stock Performers List - newser.com
How sentiment analysis helps forecast Portage Biotech Inc.Insider Selling & Weekly Top Gainers Trade List - newser.com
AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update - GlobeNewswire
Published on: 2025-11-19 04:22:07 - newser.com
Is Portage Biotech Inc. stock a dividend growth opportunityWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com
What makes Portage Biotech Inc. stock attractive to growth fundsWall Street Watch & Low Risk High Reward Ideas - newser.com
Using R and stats models for Portage Biotech Inc. forecastingGDP Growth & Verified High Yield Trade Plans - newser.com
Is Portage Biotech Inc. stock entering bullish territoryQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
AlphaTON Capital Selects P2P.org as First Institutional Staking Partner for TON Treasury Operations - markets.businessinsider.com
Regression analysis insights on Portage Biotech Inc. performance2025 Dividend Review & Verified Entry Point Signals - newser.com
Momentum divergence signals in Portage Biotech Inc. chartTrade Risk Summary & Technical Pattern Alert System - newser.com
How Portage Biotech Inc. stock benefits from tech adoptionQuarterly Market Review & Stepwise Trade Execution Plans - newser.com
Finanzdaten der Portage Biotech Inc-Aktie (PRTG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):